{"schema_version":"secwatch.filing_event.v1","accession":"0001179929-23-000095","form_type":"8-K","ticker":"MOH","cik":"0001179929","company_name":"MOLINA HEALTHCARE, INC.","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.326091+00:00","generated_at":"2026-06-13T02:13:59.889548+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"medium","headline":"Molina Healthcare Q2 GAAP EPS $5.35, adj. $5.65; raises full-year guidance","bullets":["GAAP EPS $5.35, adjusted EPS $5.65; net income $309M, up 24.6% YoY ($248M).","Premium revenue $8.04B, total revenue $8.33B; medical care ratio 87.5% improved from 88.1%.","Full-year 2023 EPS guidance raised; specific range not disclosed in filing excerpt.","G&A ratio 7.4% vs 6.8% prior year; after-tax margin 3.7% vs 3.1%."],"urls":{"canonical":"https://secwatch.observer/filing/0001179929-23-000095","json":"https://secwatch.observer/filing/0001179929-23-000095.json","markdown":"https://secwatch.observer/filing/0001179929-23-000095.md","text":"https://secwatch.observer/filing/0001179929-23-000095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1179929/000117992923000095/0001179929-23-000095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1179929/000117992923000095/moh-20230726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:13:59.889548+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"081c5050054b8d518ad5f21ad2a9f5d99f2c698c","claim":"MOLINA HEALTHCARE, INC. reported the second quarter ended June 30, 2023 results: revenue $8,327, net income $309, EPS $5.35. Guidance raised.","evidence_excerpt":"Three months ended Six months ended June 30, June 30, 2023 2022 2023 2022 (In millions, except per-share results) Premium Revenue $8,042 $7,799 $15,927 $15,330 Total Revenue $8,327 $8,054 $16,476 $15,824 GAAP: Net Income $309 $248 $630 $506 EPS – Diluted $5.35 $4.25 $10.87 $8.63 Medical Care Ratio (MCR) 87.5 % 88.1 % 87.3 % 87.6 % G&A Ratio 7.4 % 6.8 % 7.3 %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992923000095/0001179929-23-000095-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$8,327"},{"label":"Net income","value":"$309"},{"label":"EPS","value":"$5.35"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}